ISSUE 80 I MARCH 2019

the scottish

uprising

Scotland's pharmaceutical industry is booming, but how can the country maintain its status as an industry leader?

In association with

02/24/2024 18:07:17

02/20/2019 00:00:00

Go to article: Home | The Scottish Uprising Go to article: In this issue Go to article: NSF Go to article: Contents Go to article: Daiichi Jitsugyo Go to article: News Go to article: Hapa Company Insight Go to article: Bioadvice Go to article: The pharma industry briefing Go to article: Komtur Pharmaceuticals Company Insight Go to article: Komtur Pharmaceuticals Go to article: Where is the UK’s supply of Migraleve?Go to article: AtoZ-CRO GmbH Company Insight Go to article: AtoZ-CRO GmbH Go to article: Drugs from corn? Harvesting Mirexus’ phytoglycogen nano-particle Go to article: Phoenix Group Company Insight Go to article: Phoenix Group Go to article: Castleman disease: does machine learning hold the key to better treatment?Go to article: Capsugel Company Insight Go to article: Callery Go to article: A health check for Scotland’s pharmaceutical industry Go to article: ImmuMap Company Insight Go to article: ImmuMap Go to article: Moderna’s gamble: what’s behind biotech’s biggest-ever IPO?Go to article: Centaur Clinical | Company Insight Go to article: Centaur Clinical Go to article: DelSiTech: leveraging silica’s properties to improve drug delivery Go to article: Alpex Pharma Go to article: Albypharma Go to article: ‘Gene genie’: can CRISPR/Cas9 deliver on its promise to transform genome therapy?Go to article: Zenatek Go to article: Events Go to article: Sanofi Go to article: Event: CPhl Japan Go to article: Pfanstiehl Go to article: Next issue